Plaintiff Failed to Prove Product Identification in Propoxyphene Case Against Xanodyne, Ky. Judge Rules

COVINGTON, Ky. — A Kentucky federal judge has granted Xanodyne Pharmaceuticals Inc. summary judgment in propoxyphene injury case, finding the plaintiff failed to show that she ingested a propoxyphene-containing product manufactured by the drug maker.

On April 7, Judge Danny C. Reeves of the U.S. District Court for the Eastern District of Kentucky explained that Ohio law requires proof of product identification as a prerequisite to liability.

Ohio resident Judy Schiller sued Xanodyne Pharmaceuticals Inc., alleging injury caused by propoxyphene-containing prescription drugs. Her suit was transferred to the Eastern District of Kentucky for inclusion in the Darvocet/Darvon multidistrict litigation proceedings …